vs

Side-by-side financial comparison of HIVE Digital Technologies Ltd. (HIVE) and STEM, INC. (STEM). Click either name above to swap in a different company.

HIVE Digital Technologies Ltd. is the larger business by last-quarter revenue ($93.1M vs $47.1M, roughly 2.0× STEM, INC.). STEM, INC. runs the higher net margin — -33.9% vs -98.1%, a 64.2% gap on every dollar of revenue. On growth, HIVE Digital Technologies Ltd. posted the faster year-over-year revenue change (218.6% vs -15.6%). Over the past eight quarters, HIVE Digital Technologies Ltd.'s revenue compounded faster (102.2% CAGR vs 36.1%).

Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.

StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.

HIVE vs STEM — Head-to-Head

Bigger by revenue
HIVE
HIVE
2.0× larger
HIVE
$93.1M
$47.1M
STEM
Growing faster (revenue YoY)
HIVE
HIVE
+234.1% gap
HIVE
218.6%
-15.6%
STEM
Higher net margin
STEM
STEM
64.2% more per $
STEM
-33.9%
-98.1%
HIVE
Faster 2-yr revenue CAGR
HIVE
HIVE
Annualised
HIVE
102.2%
36.1%
STEM

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
HIVE
HIVE
STEM
STEM
Revenue
$93.1M
$47.1M
Net Profit
$-91.3M
$-16.0M
Gross Margin
-27.1%
48.9%
Operating Margin
-17.7%
Net Margin
-98.1%
-33.9%
Revenue YoY
218.6%
-15.6%
Net Profit YoY
-234.0%
68.8%
EPS (diluted)
$-0.38
$-4.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HIVE
HIVE
STEM
STEM
Q4 25
$93.1M
$47.1M
Q3 25
$87.3M
$38.2M
Q2 25
$45.6M
$38.4M
Q1 25
$32.5M
Q4 24
$29.2M
$55.8M
Q3 24
$22.6M
$29.3M
Q2 24
$32.2M
$34.0M
Q1 24
$25.5M
Net Profit
HIVE
HIVE
STEM
STEM
Q4 25
$-91.3M
$-16.0M
Q3 25
$-15.8M
$-23.8M
Q2 25
$35.0M
$202.5M
Q1 25
$-25.0M
Q4 24
$68.2M
$-51.1M
Q3 24
$80.0K
$-148.3M
Q2 24
$-18.3M
$-582.3M
Q1 24
$-72.3M
Gross Margin
HIVE
HIVE
STEM
STEM
Q4 25
-27.1%
48.9%
Q3 25
4.7%
35.5%
Q2 25
-13.6%
33.4%
Q1 25
32.4%
Q4 24
-43.7%
-4.4%
Q3 24
-66.1%
21.2%
Q2 24
-7.4%
27.6%
Q1 24
-95.0%
Operating Margin
HIVE
HIVE
STEM
STEM
Q4 25
-17.7%
Q3 25
-33.6%
Q2 25
-34.8%
Q1 25
-65.0%
Q4 24
-84.4%
Q3 24
-493.2%
Q2 24
-1705.5%
Q1 24
-267.0%
Net Margin
HIVE
HIVE
STEM
STEM
Q4 25
-98.1%
-33.9%
Q3 25
-18.1%
-62.2%
Q2 25
76.8%
527.8%
Q1 25
-76.9%
Q4 24
233.2%
-91.6%
Q3 24
0.4%
-506.3%
Q2 24
-56.7%
-1712.6%
Q1 24
-283.9%
EPS (diluted)
HIVE
HIVE
STEM
STEM
Q4 25
$-0.38
$-4.40
Q3 25
$-0.07
$-2.84
Q2 25
$0.18
$-1.79
Q1 25
$-0.15
Q4 24
$0.52
$-15.29
Q3 24
$0.00
$-18.24
Q2 24
$-0.17
$-71.81
Q1 24
$-0.46

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HIVE
HIVE
STEM
STEM
Cash + ST InvestmentsLiquidity on hand
$48.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$559.3M
$-249.4M
Total Assets
$624.0M
$308.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HIVE
HIVE
STEM
STEM
Q4 25
$48.9M
Q3 25
$43.1M
Q2 25
$40.8M
Q1 25
$58.6M
Q4 24
$40.5M
$56.3M
Q3 24
$31.7M
$75.4M
Q2 24
$89.6M
Q1 24
$112.8M
Stockholders' Equity
HIVE
HIVE
STEM
STEM
Q4 25
$559.3M
$-249.4M
Q3 25
$624.6M
$-235.7M
Q2 25
$560.5M
$-214.1M
Q1 25
$-417.5M
Q4 24
$430.9M
$-398.4M
Q3 24
$275.5M
$-344.1M
Q2 24
$268.6M
$-203.2M
Q1 24
$371.6M
Total Assets
HIVE
HIVE
STEM
STEM
Q4 25
$624.0M
$308.9M
Q3 25
$693.0M
$362.6M
Q2 25
$628.7M
$379.2M
Q1 25
$405.1M
Q4 24
$478.6M
$437.4M
Q3 24
$334.7M
$537.8M
Q2 24
$691.5M
Q1 24
$1.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HIVE
HIVE
STEM
STEM
Operating Cash FlowLast quarter
$46.0M
$8.2M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HIVE
HIVE
STEM
STEM
Q4 25
$46.0M
$8.2M
Q3 25
$-10.6M
$11.4M
Q2 25
$10.2M
$-21.3M
Q1 25
$8.5M
Q4 24
$-28.5M
$-14.7M
Q3 24
$-2.2M
$-9.4M
Q2 24
$-4.4M
$-11.9M
Q1 24
$-621.0K
Free Cash Flow
HIVE
HIVE
STEM
STEM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$-55.5M
Q3 24
$-34.7M
Q2 24
Q1 24
FCF Margin
HIVE
HIVE
STEM
STEM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-189.9%
Q3 24
-153.4%
Q2 24
Q1 24
Capex Intensity
HIVE
HIVE
STEM
STEM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
92.5%
Q3 24
143.9%
Q2 24
Q1 24
Cash Conversion
HIVE
HIVE
STEM
STEM
Q4 25
Q3 25
Q2 25
0.29×
-0.11×
Q1 25
Q4 24
-0.42×
Q3 24
-26.94×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons